Oklahoma
Prescription drug spending and prescribing in Oklahoma, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $3.3B for prescriptions written in Oklahoma, the 28th most of 52 states and territories, and 4.8% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $3.3B
- Medicaid drugs, 2025: $1.0B
- Opioid share of claims: 4.8%
- Life-science raises, 2 years: $34M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Oklahoma | United States | Difference |
|---|---|---|---|
| Opioids | 4.8% | 3.5% | +35% |
| Antibiotics | 4.5% | 4.4% | +1% |
| Antipsychotics | 1.6% | 1.7% | -9% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Oklahoma's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Buprenorphine Hcl | 3.4× | 24,014 |
| Buprenorphine | 2.5× | 15,803 |
| Colestipol Hcl | 2.4× | 15,250 |
| Ramelteon | 2.0× | 5,463 |
| Progesterone, Micronized | 2.0× | 16,147 |
| Sulfasalazine | 2.0× | 14,131 |
| Promethazine Hcl | 2.0× | 31,596 |
| Deutetrabenazine | 1.9× | 5,795 |
| Vortioxetine Hydrobromide | 1.9× | 14,361 |
| Cyanocobalamin (Vitamin B-12) | 1.9× | 8,256 |
Biggest Medicaid Drugs
What Oklahoma's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
9 Form D raises by companies based in Oklahoma in the last two years; the 10 largest. See all raises- Lumata Health Inc.$23M · Other health care · Feb 11, 2025
- Endless Corp$4M · Biotech · Jan 6, 2025
- Endeavor Orthopaedics, Inc.$3M · Other health care · Jun 1, 2026
- Cadenza Bio, Inc.$2M · Biotech · Aug 28, 2025
- 9960 Broadway Land, LLC$993K · Hospitals and physicians · Jan 5, 2026
- InControl Imaging Investors Moore, LLC$300K · Other health care · Nov 6, 2025
- Endless Corp$100K · Biotech · Aug 19, 2026
- MOAT BIOTECHNOLOGY Corp$26K · Biotech · Oct 20, 2025
- Jotero LLC$22K · Other health care · Aug 29, 2025
State Attorney General Health-Care Cases
Antitrust cases Oklahoma joined, newest first; see every case- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- Alabama et al. v. Endo International, No. 3:19-cv-04157 (N.D. Cal. July 19, 2019)2019 · Settled
- California et al. v. Teikoku Seikayu Co.(Lidoderm), No. 3:18-cv-00675 (N.D. Cal. 01/31/18)2018 · Settled
- State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
- State of Colorado et al v. Warner Chilcott, 1:05-cv-02182 (D.D.C.2005)2005 · Settled
- Maryland et al. v. Perrigo Company, No. 1:04CV01398 (D.D.C. Aug. 17, 2004)2004 · Settled
- Texas et al. v. Organon (Remeron), No. 04-5126 (D.N.J. 2004)2004 · Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG